Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 15/2023

Inhalt (70 Artikel)

Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study

  • Open Access
  • Research

Tongchao Jiang, Haishuang Sun, Na Li, Tongcui Jiang

A prognostic nomogram for predicting recurrence-free survival of stage I–III colon cancer based on immune-infiltrating Treg-related genes

  • Open Access
  • Research

Longwen Xu, Mengjie Liu, Jie Lian, Enmeng Li, Chang Dongmin, Xuqi Li, Wenjuan Wang

An alternative extension of telomeres related prognostic model to predict survival in lower grade glioma

  • Research

Yaning Cai, Hao Guo, JinPeng Zhou, Gang Zhu, Hongwen Qu, Lingyu Liu, Tao Shi, Shunnan Ge, Yan Qu

Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients

  • Research

Hanxiao Cui, Xueting Ren, Xuyan Zhao, Luyao Dai, Dandan Liu, Yuanhang Bao, Liqun Hu, Zhengtao Xiao, Xiaobin Ma, Huafeng Kang

A novel tetraspanin-related gene signature for predicting prognosis and immune invasion status of lung adenocarcinoma

  • Open Access
  • Research

Yindong Zhu, Ying Yang, Yuan Liu, Hongyan Qian, Ganlin Qu, Weidong Shi, Jun Liu

Expression profiling of luminal B breast tumor in Indian women

  • Research

Kayalvili Ulaganathan, Kaushik Puranam, Srinivasulu Mukta, Surekha Rani Hanumanth

Development and validation of a predictive model for penile cancer based on the surveillance, epidemiology, and end results database and multi-center cases

  • Research

Shujun Yang, Wei Chang, Bin Zhang, Qian Hou, Biao Zhang, Yindong Kang, Yongsheng Yin, Jianghou Wan, Panfeng Shang

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma

  • Open Access
  • Research

K. C. E. Drechsel, S. L. Broer, F. S. Stoutjesdijk, J. W. R. Twisk, M. H. van den Berg, C. B. Lambalk, F. E. van Leeuwen, A. Overbeek, M. M. van den Heuvel-Eibrink, W. van Dorp, A. C. H. de Vries, J. J. Loonen, H. J. van der Pal, L. C. Kremer, W. J. Tissing, B. Versluys, G. J. L. Kaspers, E. van Dulmen-den Broeder, M. A. Veening

The clinical application of atorvastatin in patients with small-cell lung cancer with dyslipidemia

  • Research

Fanming Kong, Na Wang, Fangfang Gao, Yangyueying Liang, Longhui Li, Minghui Yu, Lu Zhao, Dou Zhang, Yingjie Jia

Liquid nitrogen frozen cells for chemotherapy drug delivery and vaccination of melanoma

  • Research

Minliang Wu, Yuai Xiao, Jianguo Huang, Yuchong Wang, Yifan Zhang, Jianguo Xu, Haiying Dai, Chuan Lv, Yihui Hu, Bingdi Chen, Qingge Fu, Wenjun Le, Chunyu Xue

Kidney sparing surgery in upper tract urothelial carcinoma: paradigm change in surgical treatment for ureter cancer

  • Research

Dongsu Kim, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Bumsik Hong

Development and validation of nomograms to recurrence and survival in patients with early-stage cervical adenocarcinoma

  • Open Access
  • Research

Xintao Wang, Wenpei Shi, Xiaowen Pu, Yan Hu, Ruiying Chen, Haiyan Zhu

Association of survivin positive circulating tumor cell levels with immune escape and prognosis of osteosarcoma

  • Research

Jili Lu, Haijun Tang, Lin Chen, Nenggan Huang, Guofang Hu, Chong Li, Kai Luo, Feicui Li, Shangyu Liu, Shijie Liao, Wenyu Feng, Xinli Zhan, Jifeng Miao, Yun Liu

Comprehensive analysis of resistance mechanisms to EGFR–TKIs and establishment and validation of prognostic model

  • Research

Zhengzheng Yang, Haiming Li, Tongjing Dong, Guangda Li, Dong Chen, Shujiao Li, Yue Wang, Yuancan Pan, Taicheng Lu, Guowang Yang, Ganlin Zhang, Peiyu Cheng, Xiaomin Wang

Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma

  • Research

Kun Peng, Ning Wang, Qingyuan Liu, Lingdian Wang, Xiaoyu Duan, Guochong Xie, Jixi Li, Degang Ding

AML consolidation therapy: timing matters

  • Open Access
  • Research

Adrian-Manuel Reimann, Enrico Schalk, Felix Jost, Dimitrios Mougiakakos, Daniela Weber, Hartmut Döhner, Christian Récher, Pierre-Yves Dumas, Marc Ditzhaus, Thomas Fischer, Sebastian Sager

Characteristics and predictors associated with cancer-related fatigue among solid and liquid tumors

  • Research

Poolakkad S. Satheeshkumar, Roberto Pili, Joel B. Epstein, Sudheer B. Kurunthatil Thazhe, Rhine Sukumar, Minu Ponnamma Mohan

Can AI-based body composition assessment outperform body surface area in predicting dose-limiting toxicities for colonic cancer patients on chemotherapy?

  • Open Access
  • Research

Ke Cao, Josephine Yeung, Yasser Arafat, CheukShan Choi, Matthew Y. K. Wei, Steven Chan, Margaret Lee, Paul N. Baird, Justin M. C. Yeung

A novel model based on disulfidptosis-related genes to predict prognosis and therapy of bladder urothelial carcinoma

  • Research

Shiyong Xin, Ruixin Li, Junjie Su, Qiong Cao, Haojie Wang, Zhihao Wei, Guanyu Li, Wang Qin, Zheng Zhang, Chengliang Wang, Chengdong Zhang, Jianguo Zhang

Comprehensive analysis of CPSF4-related alternative splice genes in hepatocellular carcinoma

  • Open Access
  • Research

Anwaier Yuemaierabola, Jun Guo, Lili Sun, Buerlan Yeerkenbieke, Fuzhong Liu, Dilinaer Ye, Xiaoyi Zhai, Wenjia Guo, Yan Cao

Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience

  • Open Access
  • Research

Luc M. Berclaz, Anton Burkhard-Meier, Philipp Lange, Dorit Di Gioia, Michael Schmidt, Thomas Knösel, Frederick Klauschen, Michael von Bergwelt-Baildon, Volker Heinemann, Philipp A. Greif, C. Benedikt Westphalen, Kathrin Heinrich, Lars H. Lindner

NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer

  • Open Access
  • Research

Viktoria Florentine Koehler, Josefine Achterfeld, Natalie Sandner, Christine Koch, Jonas Paul Wiegmann, Philipp Ivanyi, Lukas Käsmann, Renate Pusch, Dominik Wolf, Mihaela Chirica, Thomas Knösel, Melanie-Christin Demes, Joerg Kumbrink, Thomas J. Vogl, Gesine Meyer, Christine Spitzweg, Joerg Bojunga, Matthias Kroiss

A nomogram was developed using clinicopathological features to predict postoperative liver metastasis in patients with colorectal cancer

  • Research

Xinyu Dou, Jiaona Xi, Gaozan Zheng, Guangming Ren, Ye Tian, Hanjun Dan, Zhenyu Xie, Liaoran Niu, Lili Duan, Ruikai Li, Hongze Wu, Fan Feng, Jianyong Zheng

Epidemiology of and factors associated with overall survival for patients with head and neck adenoid cystic carcinoma

  • Research

Dongjie He, Siying Zhu, Qianqian Zhao, Hao Chang, Gaiyan Li, Qiuju Shao, Chao Zhang, Peiwen Wu

Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma

  • Open Access
  • Research

Kevin C. Flanagan, Jon Earls, Ian Schillebeeckx, Jeffrey Hiken, Rachel L. Wellinghoff, Natalie A. LaFranzo, Zachary S. Bradley, Joey Babbitt, William H. Westra, Raymond Hsu, Lincoln Nadauld, Howard Mcleod, Sean D. Firth, Brittany Sharp, Josh Fuller, Vera Vavinskaya, Leisa Sutton, Ida Deichaite, Samuel D. Bailey, Vlad C. Sandulache, Matthew J. Rendo, Orlan K. Macdonald, Karim Welaya, James L. Wade III, Andrew W. Pippas, Jennifer Slim, Bruce Bank, Steven J. Saccaro, Xingwei Sui, Adil Akhtar, Savitha Balaraman, Steven E. Kossman, Scott A. Sonnier, Todd D. Shenkenberg, Warren L. Alexander, Katherine A. Price, Charles L. Bane, Jessica Ley, David N. Messina, Jarret I. Glasscock, Ezra E. W. Cohen, Douglas R. Adkins, Eric J. Duncavage

Financial conflicts of interest of physicians followed by oncology journals on Twitter

  • Research

Colton Betts, Akash Kakkilaya, Satvik Vasireddy, Neha Arora, Vinay Prasad, Kerrington Powell

Maternal and perinatal outcomes of pregnant patients with colorectal cancer: a population-based study

  • Research

Chengu Niu, Jing Zhang, Melody Sun, Hassan Saeed, Yujing Han, Patrick I. Okolo 3rd

Clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in postpartum women with breast cancer

  • Open Access
  • Research

He Dou, Siyuan Jia, Yuling Ba, Danli Luo, Pingyang Yu, Fucheng Li, Youyu Wang, Xingyan Chen, Min Xiao

A novel coiled-coil domain containing-related gene signature for predicting prognosis and treatment effect of breast cancer

  • Research

Yufei Wang, Yanmei Wang, Jia Zhou, Pingting Ying, Zhuo Wang, Yan Wu, Minyan Hao, Shuying Qiu, Hongchuan Jin, Xian Wang

A novel nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy

  • Research

Zhenkai Luo, Binbin Jiao, Yangxuanyu Yan, Yuhao Liu, Haijie Chen, Yunfan Guan, Zhenshan Ding, Guan Zhang

Identification of potential pseudogenes for predicting the prognosis of hepatocellular carcinoma

  • Research

Luqi Ge, Tiefeng Jin, Wanli Zhang, Zhentao Zhang, Yiwen Zhang, Xiaoping Hu, Wen Zhang, Feifeng Song, Ping Huang

Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study

  • Research

Yi Jiang, Lu Guo, Lei Han, Han Li, Changlun Li, Lianbin Wen, Yanqiong Song, Zhaoyang Wang, Pan Wang, Qulian Guo, Wenxi Zhao, Mengxiang Liu, Jiali Chen, Zhenying Wu, Yushan Yan, Ke Xu, Tao Gu, Xue Wu, Kun He, Ke Su, Yunwei Han

Development and verification of a deep learning-based m6A modification model for clinical prognosis prediction of renal cell carcinoma

  • Research

Siteng Chen, Encheng Zhang, Tuanjie Guo, Tao Wang, Jinyuan Chen, Ning Zhang, Xiang Wang, Junhua Zheng

Pancreatic cancer: experience from an emerging country in North Africa

  • Research

Fakhrddine Amri, Hajar Koulali, Rachid Jabi, Abdelkrim Zazour, Mohammed Bouziane, Zahi Ismaili, Ghizlane Kharrasse

A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer

  • Open Access
  • Research

Qiao-Yan Zhu, Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Rong Wang, Xiao-Lin Li, Wei-Wu Ye, Xiao-Wen Ding, Xiao-Jia Wang, Wen-Ming Cao

Glial cell-derived soluble factors increase the metastatic potential of pancreatic adenocarcinoma cells and induce epithelial-to-mesenchymal transition

  • Open Access
  • Research

Balbina García-Reyes, Ivan Kuzmanov, Reiner Schneider, Bianca Schneiker, Patrik Efferz, Jörg C. Kalff, Sven Wehner

Impact of the COVID-19 pandemic on oncological care in Germany: rapid review

  • Open Access
  • Review

Karina Karolina De Santis, Stefanie Helmer, Benjamin Barnes, Klaus Kraywinkel, Maren Imhoff, Roxana Müller-Eberstein, Mathia Kirstein, Anna Quatmann, Julia Simke, Lisa Stiens, Lara Christianson, Hajo Zeeb

Second-hand smoke exposure and cervical cancer: a systematic review and meta-analysis

  • Review

Maria Chiara Malevolti, Caterina Maci, Alessandra Lugo, Irene Possenti, Silvano Gallus, Giuseppe Gorini, Giulia Carreras

Microbiota as the unifying factor behind the hallmarks of cancer

  • Open Access
  • Review

Iva Benešová, Ľudmila Křížová, Miloslav Kverka

ChatGPT and oncological applications: comment

  • Correspondence

Amnuay Kleebayoon, Viroj Wiwanitkit

How detection of immune-related adverse events fails during transfer of patients between medical sectors

  • Correspondence

Kerstin Schmoranz, Cathrin Schötz, Daniel Merkel, Diana Lüftner

GUEST EDITORIAL: Theranostics in breast cancer—a vision

  • Open Access
  • Correspondence

Hans-Jürgen Biersack, Klaus Höffken

Neu im Fachgebiet Onkologie

Frühe CLL-Therapie: BTK-Hemmer verlängert EFS und PFS, aber nicht OS

Auch nach sechs Jahren ergibt sich kein Überlebensvorteil einer Therapie mit dem BTK-Hemmer Ibrutinib für Menschen mit frühem CLL-Stadium und erhöhtem Progressionsrisiko. Die Progressionsrate wird mit der Behandlung jedoch um über 80% gesenkt.

Adjuvantes Atezolizumab ohne Nutzen bei frühem TNBC

Patientinnen mit frühem triple-negativem Brustkrebs profitieren nach der Operation offenbar nicht von einer Zugabe des PD-L1-Hemmers Atezolizumab zur adjuvanten Standardchemotherapie. Die Studie, die das untersucht hat, wurde vorzeitig abgebrochen. Was könnte die schlechte Wirksamkeit erklären?

Brustkrebstherapie: zu wenig Aufklärung über Nebenwirkungen?

Ergebnisse eines internationalen Surveys legen nahe, dass die Aufklärung über Nebenwirkungen einer Brustkrebstherapie häufig unzureichend ausfällt bzw. zu spät erfolgt.

Neue chemotherapiefreie Kombinationstherapie punktet bei CLL

Zwischenergebnisse der Phase-III-Studie AMPLIFY sprechen dafür, dass die zeitlich begrenzte Behandlung mit Acalabrutinib und Venetoclax fitte Personen mit chronischer lymphatischer Leukämie länger leben lässt als eine Chemoimmuntherapie.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.